Carpolobia lutea G. Don (Polygalaceae) Inhibits Inflammation and Oxidative Stress in an Acetic Acid Induced Model of Rat Colitis

Abstract

Carpolobia lutea G. Don (CL) is used in folk medicine for the treatment of inflammatory disorders. Effort in this study is to evaluate the beneficial effect of the aqueous-methanol extract of leaf of CL in a rat model of acetic acid induced colitis. Male Wistar rats were distributed into 6 groups of 7 rats each; non colitic, untreated colitic and colitic rats treated with graded doses of CL (100–800 mg/kg). Rats were pre-treated for 2 days before colitis induction and thereafter for 7 days post colitic induction. 24 h after the last treatment, animals were sacrificed and colonic inflammation was evaluated both macroscopically and biochemically. Macroscopic damage score, weight/length ratio, myeloperoxidase (MPO) activity and tumor necrotic factor alpha (TNF-α) levels, were significantly higher in untreated colitic rats in comparison with non colitic rats (P<0.05). Treatment with CL significantly reduced the macroscopic damage scores, neutrophil infiltration (MPO activity) and TNF-α level (P<0.05). In addition, C. lutea significantly prevented depletion of colonic GSH and (SOD) levels (P<0.05). It appears that the beneficial effect of methanol extract of C. lutea leaf observed in this study is dose dependent and is related to its antioxidant and anti-inflammatory activity.

Key words

Carpolobia lutea - colitis - rats - glutathione - superoxide dismutase - myeloperoxidase - tumour necrotic factor alpha (TNF-α)

• References

• 1 Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature 2011; 474: 307-317
• 2 Sutherland L, Macdonald JK. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2006; CD000544 Review. Update in: Cochrane Database Syst Rev 2012; 10: CD000544
• 3 Nielsen OH, Munck LK. Drug insight: aminosalicylates for the treatment of IBD. Nat Clin Pract Gastroenterol Hepatol 2007; 4: 160-170 Review
• 4 Siegel CA. Review article: explaining risks of inflammatory bowel disease therapy to patients. Alimentary Pharmacology & Therapeutics 2011; 33: 23-32
• 5 Irvine FR. Woody Plants of Ghana. London: Oxford University Press; 1961: 86
• 6 Lewis WH, Elvin-Lewis MP. Medical Botany. New York: JohnWiley and Sons; 1977: 1-51
• 7 Ajibesin KK, Ekpo AB, Bala DN et al. Ethnobotanical survey of Akwa Ibom state of Nigeria. J Ethnopharmacol 2008; 115: 387-408
• 8 Iwu MM, Ayanwu BN. Phytotherapeutic profile of Nigerian herbs. I: Anti-inflammatory and anti-arthritic agents. J Ethnopharmacol 1982; 6: 263-274
• 9 Nwafor PA, Bassey AI. Evaluation of the anti-diarrhoeal and anti-ulcerogenic potential of ethanol extract of Carpolobia lutea leaves in rodents. J Ethnopharmacol 2007; 111: 619-624
• 10 Bero J, Ganfon H, Jonville MC et al. In vitro antiplasmodial activity of plants used in Benin in traditional medicine to treat malaria. J Ethnopharmacol 2009; 122: 439-444
• 11 Bero J, Hannaert V, Chataigné G et al. In vitro antitrypanosomal and antileishmanial activity of plants used in Benin in traditional medicine and bio-guided fractionation of the most active extract. J Ethnopharmacol 2011; 137: 998-1002
• 12 Nwidu LL, Essien GE, Nwafor PA et al. Antidiarrheal mechanism of Carpolobia lutea leaf fractions in rats. Pharm Biol 2011; 49: 1249-1256
• 13 Nwidu LL, Nwafor PA, Vilegas W. Antimicrobial activity of Carpolobia lutea G. Don (Polygalaceae) extracts and fractions and isolated compounds. Afr J Altern Compl Med 2012; 9: 323-328
• 14 Nwidu LL, Cilli EM, Vilegas W. Amino acid, Antioxidant and ion profiles of Carpolobia lutea Leaf (Polygalaceae). Trop J Pharm Res 2012; 11: 807-813
• 15 Nwidu LL, Nwafor PA. Anti-inflammatory and antipyretic effect of Carpolobia lutea Leaf extract in rodents. Int Res J Pharm 2012; 3: 154-160
• 16 Akpan MM, Okokon JE, Akpan EJ. Antidiabetic and hypolipidemic activities of ethanolic leaf extract and fractions of Carpolobia lutea. Mol Clin Pharmacol 2012; 3: 100-107
• 17 Morris GP, Beck PL, Herridge MS et al. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96: 795-803
• 18 Camuesco D, Peran L, Comalada M et al. Preventative effects of lactulose in the trinitrobenzene sulphonic acid model of rat colitis. Inflamm Bowel Disease 2005; 11: 265-271
• 19 Anderson ME. Determination of glutathione and glutathione disulfide in biological samples. Methods in Enzymology 1985; 113: 548-555
• 20 Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972; 247: 3170-3175
• 21 Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity assessment of inflammation in rat and hamster models. Gastroenterology 1984; 87: 1344-1350
• 22 Park MY, Ji GE, Sung MK. Dietary kaempferol suppresses inflammation of dextran sulfate sodium-induced colitis in mice. Dig Dis Sci 2012; 57: 355-363
• 23 Masoodi I, Tijjani BM, Wani H et al. Biomarkers in the management of ulcerative colitis: a brief review. Ger Med Sci 2011; 9: 03
• 24 Randhawa PK, Singh K, Singh N et al. A Review on Chemical-Induced Inflammatory Bowel Disease Models in Rodents. Korean J Physiol Pharmacol 2014; 18: 279-288
• 25 Joshi SV, Vyas BA, Shah PD et al. Protective effect of aqueous extract of Oroxylumindicum Linn. (root bark) against DNBS-induced colitis in rats. Indian J Pharmacol 2011; 43: 656-661
• 26 Algieri F, Rodríguez-Nogales A, Garrido-Mesa N et al. Intestinal anti-inflammatory effects of oligosaccharides derived from lactulose in the trinitrobenzene sulfonic acid model of rat colitis. Journal of Agric Food Chem 2014; 62: 4285-4297
• 27 Aleisa AM, Al-Rejaie SS, Abuohashish HM et al. Pretreatment of Gymnema Sylvestre revealed the protection against acetic acid-induced ulcerative colitis in rats. BMC Complement Altern Med 2014; 14: 49
• 28 Elson CO, Sartor RB, Tennyson GS et al. Experimental models of inflammatory bowel disease. Gastroenterology 1995; 109: 1344-1367
• 29 Ogunwande IA, Flamini G, Avoseh NO et al. Essential oil of Carpolobia lutea. Chem Nat Compd 2014; 50: 373-375
• 30 Mitaine-Offer AC, Miyamoto T, Khan IA et al. Three new triterpene saponins from two species of Carpolobia. J Nat Prod 2002; 65: 553-557
• 31 Wagner KH, Elmadfa I. Biological relevance of terpenoids. Overview focusing on mono-, di- and tetraterpenes. Ann Nutr Metab 2003; 47: 95-106
• 32 Rabi T, Bishayee A. Terpenoids and breast cancer chemoprevention. Breast Cancer Res Treat 2009; 115: 223-239
• 33 Thakur M, Melzig MF, Fuchs H et al. Chemistry and pharmacology of saponins: Special focus on cytotoxic properties. Bots Tar Ther 2011; 1: 19-29
• 34 Bi L, Tian X, Dou F et al. New antioxidant and antiglycation active triterpenoidsaponins from the root bark of Aralia taibaiensis. Fitoterapia 2012; 83: 234-240
• 35 Mostafa A, Sudisha J, El-Sayed M et al. Aginosidesaponin, a potent antifungal compound, secondary metabolite analyses from Allium nigrum L. Phytochem Lett 2013; 6: 274-280
• 36 Teshima Y, Ikeda T, Imada K et al. Identification and biological activity of antifungal saponins from shallot (Allium cepa L. Aggregatum group). J Agric Food Chem 2013; 61: 7440-7445
• 37 Fouedjou RT, Teponno RB, Quassinti L et al. Steroidal saponins from the leaves of Cordyline fruticosa (L.) A. Chev. and their cytotoxic and antimicrobial activity. Phytochem Lett 2014; 7: 62-68
• 38 Verza SG, Silveira F, Cibulski S et al. Immuno adjuvant activity, toxicity assays, and determination by UPLC/Q-TOF-MS of triterpenic saponins from Chenopodium quinoa seeds. J Agric Food Chem 2012; 60: 3113-3118